Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japan’s MHLW Encourages Hospitals To Embrace Treatment-specific Reimbursement System

This article was originally published in PharmAsia News

Executive Summary

TOKYO - By July 2009, a total of 1,383 Japanese hospitals, out of some 9,000 hospitals in the country, will be recognized by Japan's Ministry of Health, Labor and Welfare as medical facilities to be evaluated by a "diagnosis procedure combination," similar to the U.S. diagnosis-related group system, to receive fixed-sum National Health Insurance reimbursements for treatments in MHLW-specified disease groups, an MHLW official told PharmAsia News April 6
Advertisement

Related Content

Drug Makers Expedite Switch OTC Development, Sales After Japan Law Revision
Drug Makers Expedite Switch OTC Development, Sales After Japan Law Revision
Advertisement
UsernamePublicRestriction

Register

SC071561

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel